Pharmaceuticals company AstraZeneca is the first company in the UK to commitment to using biomethane at scale to fuel development and manufacture of medicines.

In partnership with, Future Biogas, the Moor Bioenergy plant in Lincolnshire will supply 100GWh of renewable energy annually, equivalent to 20 per cent of the company’s total global gas consumption, displacing approximately 18,000 tonnes of carbon dioxide.

AstraZeneca’s Ambition Zero Carbon goal is to use 100 per cent renewable energy for its own operations by the end of 2025 and achieve science-based net-zero by 2045.

Liz Chatwin, VP, global sustainability and SHE at AstraZeneca, said, “We are committed to climate action and innovation in sustainability to decarbonise healthcare. By investing in unsubsidised biomethane capacity, we’re proud to contribute to reducing carbon emissions while strengthening the UK’s renewable energy infrastructure.”

The plant also features innovative carbon capture technology, which collects carbon dioxide produced during biomethane generation. This CO2 can either be reused in other industries or in the longer-term it can be permanently stored underground, creating a carbon removal from the atmosphere.

Crops supplied to Moor Bioenergy will be sourced within 15 miles of the plant with local farmers supported to drive sustainable farming practices. Five-year feedstock contracts will offer farmers greater financial security, helping to mitigate the challenges of fluctuating food crop prices and climate change.

---